FDA told online seller PushMyCart its website and Facebook posts sell unapproved drugs claiming to treat measles, cancer, diabetes and Parkinson's.
What happened
FDA reviewed the website pushmycart.com in September 2025 and also looked at the company's Facebook account, which sends shoppers to that site. FDA found the products offered for sale with labeling claiming to cure, treat or prevent serious diseases such as measles, hepatitis, Parkinson's disease, diabetes, glaucoma and high blood pressure. FDA says none of the products has an approved drug application.
What FDA found
The products are drugs because their labels say they diagnose, cure, treat or prevent disease, and FDA has not approved them for those uses.
Section 505(a) of the FD&C Act, 21 U.S.C. 355(a)The products are 'new drugs' because they are not generally recognized as safe and effective for the uses on their labels.
Section 201(p) of the FD&C Act, 21 U.S.C. 321(p)The website and Facebook posts show the products are meant to treat diseases, which makes them drugs under the law.
Section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1); 21 CFR 201.128Shipping these unapproved drugs across state lines is illegal.
Sections 301(d) and 505(a) of the FD&C Act, 21 U.S.C. 331(d) and 355(a)FDA is especially concerned about the glaucoma eye drop, because medicines put into the eye bypass some of the body's natural defenses.
Calling a product homeopathic does not exempt it from the law; homeopathic drugs must still meet the same approval, misbranding and adulteration rules as other drugs.
Section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1)
What FDA wants
FDA asks the company to write to CDER's Office of Unapproved Drugs and Labeling Compliance within fifteen working days, describing each step taken to fix the violations and to prevent them from happening again. If corrections cannot be finished in that time, the company must say why and give a completion date.
Who should pay attention
- online marketplaces and e-commerce platforms hosting supplement or homeopathic listings
- retailers and distributors that stock homeopathic or Ayurvedic products
- brands whose products are resold on third-party websites
This is a summary. Read the original letter on fda.gov.